HLA-C and myeloid sarcoma: Higher weighted sum scores that included the MHC alleles increased the risk by OR = 2.16 and OR = 2.4 in MS cases compared with the population controls and control families, respectively, which decreased to 1.83 and 1.92 when the MHC alleles were excluded (Table 2).